Sartorius Stedim Biotech (SSB) agreed to acquire kSep Holdings, which develops and markets single-use, automated centrifuge systems for biomanufacturing. The transaction, valued at approximately $28 million, is expected to close by the end of the month.

“kSep’s centrifuges are a very innovative, single-use cell separation technology that perfectly complements our offering for downstream bioprocessing,” said Reinhard Vogt, member of SSB’s board. “Our clients will greatly benefit from the unique ability to collect, wash, and concentrate cells quickly and reduce both the time and cost of downstream purification steps.” SSB says it will retain kSep’s current leadership and staff. 

Previous articleVertex, Moderna Launch Cystic Fibrosis Collaboration
Next articleAbénex Acquires Cisbio Bioassays from Argos Soditic